Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Neuberg Centre For Genomic Medicine, |
RCV002510686 | SCV002820199 | uncertain significance | NAD(P)HX dehydratase deficiency | criteria provided, single submitter | clinical testing | The missense variant c.645C>G (p.Asp215Glu) in NAXD gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Asp215Glu variant is novel (not in any individuals) in 1000 Genomes and allele frequency of 0.03621% is reported in gnomAD. The amino acid Asp at position 215 is changed to a Glu changing protein sequence and it might alter its composition and physico-chemical properties. In silico tools predict the variant to be tolerated. The residue is variable across species. The amino acid change p.Asp215Glu in NAXD is predicted as conserved by PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance . | |
Labcorp Genetics |
RCV003546858 | SCV004254583 | likely benign | not provided | 2024-02-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004958563 | SCV005458197 | likely benign | Inborn genetic diseases | 2024-08-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |